70
Participants
Start Date
August 17, 2024
Primary Completion Date
May 31, 2025
Study Completion Date
June 12, 2025
JMKX003801
"For Ascending Single Dose of JMKX003801，Five（5）cohorts of 40 participants (each cohort contains 6 active and 2 placebo) are planned for evaluation.~For Ascending Multiple Dose of JMKX003801，Three（3）cohort of 30 participants (each cohort contains 8 active and 2 placebo) are planned for evaluation."
Placebo
"For Ascending Single Dose of JMKX003801，Five（5）cohorts of 40 participants (each cohort contains 6 active and 2 placebo) are planned for evaluation.~For Ascending Multiple Dose of JMKX003801，Three（3）cohorts of 30 participants (each cohort contains 8 active and 2 placebo) are planned for evaluation."
RECRUITING
Huashan Hospital Fudan University, Shanghai
Lead Sponsor
Jemincare
INDUSTRY